Inventor · disambiguated record
Jianye Wen
Also filed as: WEN JIANYE
22 granted patents·17 pending applications·102 citations·filing 1997–2025
94Inventor score
Top patents by PatentIndex Score
39 records- 0191US8383149B2High enhancer-loading polyacrylate formulation for transdermal applicationsALZA CORP·Filed 2006·Granted Feb 26, 2013·7 cites·21 claims
- 0287US9205090B2High enhancer-loading polyacrylate formulation for transdermal applicationsALZA CORP·Filed 2014·Granted Dec 8, 2015·3 cites·20 claims
- 0387US8758808B2Method of making a high enhancer-loading polyacrylate formulation for transdermal applicationsALZA CORP·Filed 2013·Granted Jun 24, 2014·3 cites·10 claims
- 0484US10772871B2Dexmedetomidine transdermal delivery devices and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2014·Granted Sep 15, 2020·3 cites·21 claims
- 0583US10987342B2Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidineTEIKOKU PHARMA USA INC·Filed 2014·Granted Apr 27, 2021·3 cites·37 claims
- 0683US10874642B2Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2019·Granted Dec 29, 2020·1 cites·16 claims
- 0781US11547676B2Extended buprenorphine transdermal delivery compositions and methods for using the sameTEIKOKU SEIYAKU KK·Filed 2013·Granted Jan 10, 2023·2 cites·13 claims
- 0879US6403686B1Rheologically-dynamic, liquid-applicable elastomeric compositionsGRACE W R & CO·Filed 2000·Granted Jun 11, 2002·19 cites·21 claims
- 0977US2024165105A1Topical naloxone compositions and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2024·Application pending·0 cites
- 1076US9205061B2Propynylaminoindan transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2013·Granted Dec 8, 2015·2 cites·18 claims
- 1176US9144553B2Compositions and methods for transdermal delivery of hormones and other medicinal agentsTEIKOKU PHARMA USA INC·Filed 2013·Granted Sep 29, 2015·2 cites·33 claims
- 1276US6689460B2Primer/membrane barrier systemGRACE W R & CO·Filed 2001·Granted Feb 10, 2004·22 cites·25 claims
- 1375US2024245652A1Methods and compositions for managing pain comprising dexmedetomidine transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2024·Application pending·0 cites
- 1474US2025302820A1Topical naloxone compositions and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2025·Application pending·0 cites
- 1571US2025099399A1Transdermal delivery patch for treating painTEIKOKU PHARMA USA INC·Filed 2024·Application pending·0 cites
- 1670US12364692B2Topical naloxone compositions and methods for using the sameTEIKOKU PHARMA USA INC·Filed 2021·Granted Jul 22, 2025·0 cites·17 claims
- 1768US10918607B2Propynylaminoindan transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2013·Granted Feb 16, 2021·0 cites·10 claims
- 1867US9017723B2Propynylaminoindan transdermal compositionsWEN JIANYE·Filed 2011·Granted Apr 28, 2015·2 cites·19 claims
- 1966US8263680B2Acrylic polymer-based adhesivesLUCIANO ALLISON·Filed 2006·Granted Sep 11, 2012·2 cites·11 claims
- 2066US8153742B2Acrylic polymer-based adhesivesLUCIANO ALLISON·Filed 2006·Granted Apr 10, 2012·2 cites·20 claims
- 2166US6072018AHigh abrasion resistant coating materialVIRGINIA TECH INTELL PROP·Filed 1997·Granted Jun 6, 2000·29 cites·19 claims
- 2263US2025275930A1Transdermal delivery patch for treating painTEIKOKU PHARMA USA INC·Filed 2025·Application pending·0 cites
- 2359US2016051488A1High enhancer-loading polyacrylate formulation for transdermal applicationsALZA CORP·Filed 2015·Application pending·0 cites
- 2457US2010080842A1Transdermal extended-delivery donepezil compositions and methods for using the sameWEN JIANYE·Filed 2009·Application pending·0 cites
- 2557US2009291127A1Transdermal anti-dementia active agent formulations and methods for using the sameWEN JIANYE·Filed 2009·Application pending·0 cites
- 2654US9827207B2Propynylaminoindan transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2015·Granted Nov 28, 2017·0 cites·18 claims
- 2754US2007104771A1Transdermal galantamine delivery systemAUDETT JAY·Filed 2006·Application pending·0 cites
- 2854US2015098983A1Methods and Compositions for Treating Withdrawal Syndromes Using Non-Sedative Dexmedetomidine Transdermal CompositionsTEIKOKU PHARMA USA INC·Filed 2014·Application pending·0 cites
- 2954US2007134310A1Transdermal risperidone delivery systemNEDBERGE DIANE E·Filed 2006·Application pending·0 cites
- 3053US2015098997A1Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal CompositionsTEIKOKU PHARMA USA INC·Filed 2014·Application pending·0 cites
- 3153US2015098982A1Methods and Compositions for Managing Pain Comprising Dexmedetomidine Transdermal CompositionsTEIKOKU PHARMA USA INC·Filed 2014·Application pending·0 cites
- 3253US2022218689A1Transdermal tropane compositions and methods for using the sameSANIONA AS·Filed 2019·Application pending·0 cites
- 3350US2019175519A1Naloxone Transdermal Delivery Devices and Methods for Using the SameTEIKOKU PHARMA USA INC·Filed 2018·Application pending·0 cites
- 3449US9579296B2Compositions and methods for transdermal delivery of hormones and other medicinal agentsTEIKOKU PHARMA USA INC·Filed 2015·Granted Feb 28, 2017·0 cites·22 claims
- 3547US9119799B2Transdermal compositions comprising an active agent layer and an active agent conversion layerHAMLIN RICHARD·Filed 2012·Granted Sep 1, 2015·0 cites·21 claims
- 3646US9597301B2Propynylaminoindan transdermal compositionsTEIKOKU PHARMA USA INC·Filed 2015·Granted Mar 21, 2017·0 cites·7 claims
- 3743US9913812B2Methods for the treatment of skin neoplasmsTEIKOKU PHARMA USA INC·Filed 2012·Granted Mar 13, 2018·0 cites·26 claims
- 3841US2016184240A1Transdermal Compositions Comprising an Active Agent Layer and An Active Agent Conversion LayerTEIKOKU PHARMA USA INC·Filed 2015·Application pending·0 cites
- 3937US2010178307A1Transdermal anti-dementia active agent formulations and methods for using the sameWEN JIANYE·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →